Factors controlling immunoglobulin production and B cell proliferationFRIDMAN, W. H.Bulletin du cancer. 1991, Vol 78, Num 2, pp 195-201, issn 0007-4551Article

Immunologie et cancers = Immunology and cancersFRIDMAN, W. H.Actualités gynécologiques (Paris. 1971). 1990, Vol 21, pp 107-114, issn 0223-4661, 8 p.Article

New immunotherapeutic approaches: the use of cytokines to stimulate the immune system or to control the growth of malignant lymphoid cellsFRIDMAN, W. H.European journal of cancer & clinical oncology. 1989, Vol 25, Num 11, pp 1525-1528, issn 0277-5379Article

Fc receptors and immunoglobulin binding factorsFRIDMAN, W. H.The FASEB journal. 1991, Vol 5, Num 12, pp 2684-2690, issn 0892-6638Article

Les récepteurs pour le fragment Fc des IgG (RFcγ) : formes membranaires et formes solubles = Receptors of the Fc portion of IgG-membrane and soluble formsSAUTES, C; FRIDMAN, W. H.Comptes rendus des séances de la Société de biologie et de ses filiales. 1994, Vol 188, Num 1, pp 11-22, issn 0037-9026Article

Les cellules de l'immunité = The cells of the immune systemSAUTES, C; FRIDMAN, W. H.Revue de pédiatrie (Paris). 1989, Vol 25, Num 3, pp 105-116, issn 0035-1644, 10 p.Article

Pathophysiology of cytokinesFRIDMAN, W. H; MICHON, J.Leukemia research. 1990, Vol 14, Num 8, pp 675-677, issn 0145-2126, 3 p.Article

V-Les cytokines et le système immunitaire = Cytokines and the immune systemSAUTES, C; FRIDMAN, W. H.Revue de pédiatrie (Paris). 1989, Vol 25, Num 6, pp 237-243, issn 0035-1644Article

Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcγR scFv on cancer cell surfaceGRUEL, N; FRIDMAN, W. H; TEILLAUD, J. L et al.Gene therapy (Basingstoke). 2001, Vol 8, Num 22, pp 1721-1728, issn 0969-7128Article

Current status of interleukin-2 therapy in cancerTARTOUR, E; MATHIOT, C; FRIDMAN, W. H et al.Biomedicine & pharmacotherapy. 1992, Vol 46, Num 10, pp 473-484, issn 0753-3322Article

The use of cytokines in the treatment of solid tumoursFRIDMAN, W. H; TARTOUR, E.Hematology and cell therapy (Print). 1997, Vol 39, Num 2, pp 105-108, issn 1269-3286Conference Paper

Anti-cytokines : promising tools for diagnosis and immunotherapyTARTOUR, E; LEE, R. S; FRIDMAN, W. H et al.Biomedicine & pharmacotherapy. 1994, Vol 48, Num 10, pp 417-424, issn 0753-3322Article

Fc receptor diversity: the mast cell caseDAERON, M; BENHAMOU, M; FRIDMAN, W. H et al.Annales de l'Institut Pasteur. Immunologie. 1986, Vol 137D, Num 2, pp 233-248, issn 0769-2625Article

Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target cellsMOHAMED LAKHDAR; SENIK, A; FRIDMAN, W. H et al.Cellular immunology (Print). 1984, Vol 83, Num 2, pp 414-421, issn 0008-8749Article

Mise en evidence de récepteurs solubles de type II pour la partie Fc des IgG (ou RFc_γIIs) dans la salive totale humaineTEILLAUD, C; FRIDMAN, W. H; SAUTES, C et al.Journal de biologie buccale. 1992, Vol 20, Num 1, pp 3-10, issn 0301-3952Article

L'immunoglobulin-G-binding factor (IgG-BF), élément clé de la production d'anticorps produit par génie génétique = The immunoglobin-G-Binding Factor (IgG-BF), a key element for antibody productionSAUTES, C; TEILLAUD, J.-L; FRIDMAN, W. H et al.Biofutur (Puteaux). 1990, Num 89, pp 57-59, issn 0294-3506Article

Murine recombinant FcγRIII, but not FCγRII, trigger serotonin release in rat basophilic leukemia cellsDAËRON, M; BONNEROT, C; LATOUR, S et al.The Journal of immunology (1950). 1992, Vol 149, Num 4, pp 1365-1373, issn 0022-1767Article

Regulation of IgG production by suppressor FcγRII⁺ T hybridomasBRUNATI, S; MONCUIT, J; FRIDMAN, W. H et al.European journal of immunology. 1990, Vol 20, Num 1, pp 55-61, issn 0014-2980Article

Selective PCR amplification of functional immunoglobulin light chain from hybridoma containing the aberrant MOPC 21-derived Vκ by PNA-mediated PCR clampingCOCHET, O; MARTIN, E; FRIDMAN, W. H et al.BioTechniques. 1999, Vol 26, Num 5, pp 818-822, issn 0736-6205, 3 p.Article

Facteur de nécrose tumorale α, interleukine 2, et IgG-BF III (CD 16): évaluation des taux sériques dans les cancers gynécologiques = Tumoral necrosis factor alpha, interleukin 2 and IgG-BF III (CD 16). Evaluation of serum levels in cancers of the female genital tractDE JACO, P. A; FRIDMAN, W. H; TEILLAUD, J. L et al.La Presse médicale (1983). 1989, Vol 18, Num 23, pp 1167-1168, issn 0755-4982, 2 p.Article

Induction of tumor necrosis factor-α production by mast cell via FcγR : role of the FCγRIIIγ subunitLATOUR, S; BONNEROT, C; FRIDMAN, W. H et al.The Journal of immunology (1950). 1992, Vol 149, Num 6, pp 2155-2162, issn 0022-1767Article

Recombinant interleukin 2-activated natural killer cells regulate IgG_2a productionAMIGORENA, S; BONNEROT, C; FRIDMAN, W. H et al.European journal of immunology. 1990, Vol 20, Num 8, pp 1781-1787, issn 0014-2980, 7 p.Article

Molecular heterogeneity of murine mast cell Fcγ receptorsBENHAMOU, M; BONNEROT, C; FRIDMAN, W. H et al.The Journal of immunology (1950). 1990, Vol 144, Num 8, pp 3071-3077, issn 0022-1767Article

A sensitive method for testing the effect of immunoglobulin binding factor on Ig secretion by hybridoma B cellsAMIGORENA, S; MONCUIT, J; FRIDMAN, W. H et al.Journal of immunological methods. 1987, Vol 97, Num 1, pp 57-64, issn 0022-1759Article

Inhibition of LAK cells by IL2-activated monocytes : role of TGF-β and PGE₂WENG, X; MATHIOT, C; LANDO, D et al.The Cancer journal (Print). 1991, Vol 4, Num 5, pp 307-315, issn 0765-7846Article